855 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Rank Status Study
21 Unknown  Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Other: drug (tacrolimus and SchE) and genetics;   Drug: tacrolimus
22 Recruiting Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Condition: Genetics of Drug Metabolism
Intervention:
23 Unknown  Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
24 Unknown  Pharmacogenomics Studies of Antidepressants
Conditions: Major Depressive Disorder;   Antidepressive Agents;   Pharmacogenetics;   Venlafaxine;   Fluoxetine
Interventions: Drug: Venlafaxine;   Drug: Fluoxetine
25 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
26 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
27 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
28 Not yet recruiting Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
Condition: Anticoagulation
Intervention: Genetic: Pharmacogenetic anticoagulation
29 Recruiting Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing
30 Unknown  Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
31 Recruiting Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness
Conditions: Depression;   Antidepressant Drug Adverse Reaction
Interventions: Drug: SSRI treated group;   Drug: non-SSRI treated group
32 Withdrawn Study Using Pharmacogenetics to Select Treatment for Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Cisplatin;   Drug: Cetuximab
33 Completed EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
Condition: HIV Infection
Intervention: Drug: Efavirenz
34 Completed
Has Results
Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy
Condition: Blood Clotting
Interventions: Genetic: warfarin pharmacogenetic dosing;   Drug: Warfarin
35 Completed Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia
Conditions: Pregnancy;   Cesarean Delivery;   General Anesthesia
Intervention: Drug: Remifentanil
36 Not yet recruiting Standard of Care Versus Urine Testing With Selective PHarmacogenomics for Effective Drug and Dosing REgimens
Condition: Target Drug-related Adverse Events
Interventions: Other: Urine diagnostic testing as SOC, drug regimen changes per SOC;   Other: Urine diagnostic testing with selective PGx testing, drug regimen changes based on PGx test results
37 Active, not recruiting Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype
Condition: Depression
Interventions: Drug: responders;   Drug: non-responders
38 Recruiting Pharmacogenomics of New Antiretrovirals
Condition: HIV
Intervention:
39 Completed CYP2D6 Pharmacogenetics in Risperidone-Treated Children
Conditions: Psychiatric Disorders;   Neurodevelopmental Disorders
Intervention:
40 Unknown  Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose
Condition: Indications for Warfarin Therapy
Intervention: Drug: Warfarin Sodium

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years